Athletes Report Favorable Outcomes at 5‐Year Minimum Follow‐Up After Primary Hip Arthroscopy: A Systematic Review
- 14 November 2022
- journal article
- review article
- Published by Wiley in Arthroscopy
- Vol. 39 (2) , 510-528
Abstract
Purpose: To evaluate minimum 5‐year outcomes and survivorship after primary hip arthroscopy in athletes. Methods: A systematic review of current literature was performed with the following key words: “hip arthroscopy,” “long‐term,” “outcomes,” “ten‐year,” “survivorship,” “10‐year,” “5‐year,” “five‐year,” “midterm,” “athlete,” “sport,” and “femoroacetabular impingement” in PubMed, Cochrane Trials, and Scopus in April 2022 using the Preferred Reporting Items for Systematic Reviews and Meta‐analyses guidelines. Study and demographic variables such as title, author, publication date, study design, demographic, number of hips, follow‐up time, study period, indications for hip arthroscopy, patient‐reported outcome scores, and rates of secondary surgeries and conversion to total hip arthroplasty. Radiographic, intraoperative surgical treatment, and clinical benefit was documented as well. Results: Ten studies that captured data on 691 hips were included in this study. Eight studies reported mean and standard deviation for the modified Harris Hip Score. Significant improvements were reported in all studies with postoperative scores ranging from 83.3 to 94.4 (standardized mean difference [SMD] 1.65; 95% confidence interval [CI] 1.39‐1.91, P < .00001). Eight studies reported significant improvement in Hip Outcome Score – Sports Specific Scale with postoperative scores ranging from 59.2 to 94.6 (SMD 1.66; 95% CI 1.33‐1.98, P < .00001). Seven studies reported significant improvement in Nonarthritic Hip Score with postoperative scores ranging from 79.6 to 95.3 (SMD 1.41; 95% CI 1.16‐1.65, P < .00001). Seven studies also reported significant improvement in VAS with postoperative scores ranging from 0.7 to 3.1 (SMD –1.57; 95% CI –1.88, –1.26, P < .00001). Nine of 10 studies reported achieving at least 1 psychometric threshold at a rate of least 75%. Rates of secondary arthroscopy and conversion to total hip arthroplasty varied from 0% to 15.2% and 0% to 33.3%. Conclusions: Athletes who underwent primary hip arthroscopy demonstrated favorable outcomes and high rates of clinical benefit at 5‐year follow‐up. In addition, they demonstrated high rates of survivorship and achieving psychometric thresholds. Level of Evidence: Level IV, systematic review of Level III and IV studies.Keywords
Funding Information
- Arthrex
- Arthrex
This publication has 26 references indexed in Scilit:
- Research Pearls: How Do We Establish the Level of Evidence?Arthroscopy, 2018
- Midterm Outcomes and Return to Sports Among Athletes Undergoing Hip ArthroscopyThe American Journal of Sports Medicine, 2018
- Femoroacetabular impingement: a common cause of hip painThe Physician and Sportsmedicine, 2018
- High Rate of Return to Swimming After Hip Arthroscopy for Femoroacetabular ImpingementArthroscopy, 2018
- Survivorship and Outcomes 10 Years Following Hip Arthroscopy for Femoroacetabular ImpingementJournal of Bone and Joint Surgery, 2017
- Incidence of symptomatic femoroacetabular impingement in the general population: a prospective registration study:Journal of Hip Preservation Surgery, 2016
- Validation of the classification system for acetabular chondral lesions identified at arthroscopy in patients with femoroacetabular impingementThe Journal of Bone and Joint Surgery. British volume, 2011
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Hip Arthroscopy in AthletesThe American Journal of Sports Medicine, 2009
- Methodological index for non‐randomized studies (MINORS): development and validation of a new instrumentAnz Journal of Surgery, 2003